Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pediaPREM
NCT05681572Phase 3Recruiting
- Sponsor
- CHU Montpellier
- Start
- Apr 2023
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of midazolam, dexmedetomidine in anxiety disorder, sponsored by CHU Montpellier. Started Apr 2023; status: recruiting.
02
Drugs
midazolamdexmedetomidine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT05681572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05681572.